Sarim Khan co-founded Triomics, which builds AI agents for oncology care and research, and leads it as CEO. Triomics went through Y Combinator (W21), and he previously did research at MIT.
Sarim Khan co-founded Triomics, which builds AI agents for oncology care and research, and leads it as CEO. Triomics went through Y Combinator (W21), and he previously did research at MIT.